MICHAEL RUSSELL CHARLTON

Allopathic & Osteopathic Physicians|Internal Medicine|Transplant Hepatology CHICAGO, IL NPI 1821064692

General Payments — all program years on this page

$306,006.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 162
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $44,827.01 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $39,563.0110
Travel and Lodging $5,264.002

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Madrigal Pharmaceuticals $26,105.512
GlaxoSmithKline, LLC. $11,289.004
BARD PERIPHERAL VASCULAR, INC. $4,550.004
Novo Nordisk AS $2,082.501
PFIZER INC. $800.001

By program year

Program yearAmountRecords
2018 $34,901.9538
2019 $58,903.4847
2020 $24,930.006
2021 $49,860.9315
2022 $52,696.3224
2023 $39,886.8420
2024 $44,827.0112

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097495281 Novo Nordisk Inc $2,082.50 05/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1115950365 GlaxoSmithKline, LLC. $1,225.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116486853 GlaxoSmithKline, LLC. $3,763.69 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116621955 GlaxoSmithKline, LLC. $4,800.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116626236 GlaxoSmithKline, LLC. $1,500.31 09/06/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1128482309 Bard Peripheral Vascular, Inc. $975.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1128482311 Bard Peripheral Vascular, Inc. $650.00 02/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1128482313 Bard Peripheral Vascular, Inc. $2,600.00 05/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1128482317 Bard Peripheral Vascular, Inc. $325.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131706169 PFIZER INC. $800.00 07/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1144163161 Madrigal Pharmaceuticals $575.51 09/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1144163163 Madrigal Pharmaceuticals $25,530.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.